Molecular modeling of buspirone-serotonin receptor interactions
Chilmonńczyk, Z.; Cybulski, J.; Bronowska, A.; Leś, A.
Acta Poloniae Pharmaceutica 57(4): 281-288
2000
ISSN/ISBN: 0001-6837 PMID: 11126617 Document Number: 518146
Modern concepts of buspirone activity as an anxiolytic drug are reviewed. Particular attention is focused on the molecular aspects of buspirone interactions in the phases that simulate cellular environment. Three-dimensional models of buspirone-serotonin receptor complexes are discussed as well.
Document emailed within 1 workday
Related Documents
Rong, S.B.; Zhu, Y.C.; Jiang, H.L.; Zhao, S.R.; Wang, Q.M.; Chi, Z.Q.; Chen, K.X.; Ji, R.Y. 1997: Molecular modeling of mu opioid receptor and receptor-ligand interaction Zhongguo Yao Li Xue Bao 18(4): 317-322Sulser, F. 1987: Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders Journal of Clinical Psychiatry 48 Suppl: 12-18
Rong, S.B.; Jiang, H.L.; Chi, Z.Q.; Chen, K.X.; Zhu, Y.C.; Ji, R.Y. 1997: Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate Zhongguo Yao Li Xue Bao 18(3): 219-224
Shpakov, A.O.; Shpakova, E.A.; Tarasenko, I.I.; Derkach, K.V.; Chistiakova, O.V.; Vlasov, G.P. 2010: Peptides derived from the third cytoplasmatic loop of serotonin 1B receptor subtype selectively inhibit serotonin signal transduction via a homologous receptor Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(11): 1062-1074
Karlin, A. 1973: Molecular interactions of the acetylcholine receptor Federation Proceedings 32(8): 1847-1853
Weiland, G.A.; Minneman, K.P.; Molinoff, P.B. 1979: Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor Nature 281(5727): 114-117
Joffe, R.T.; Schuller, D.R. 1993: An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression Journal of Clinical Psychiatry 54(7): 269-271
Phillips, K.A. 1996: An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder Psychopharmacology Bulletin 32(1): 175-180
Kohn, L.D.; Aloj, S.M.; Beguinot, F.; Vitti, P.; Yavin, E.; Yavin, Z.; Laccetti, P.; Grollman, E.F.; Valente, W.A. 1982: Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes Progress in Clinical and Biological Research 97: 55-83
Lucki, I.; Nobler, M.S.; Frazer, A. 1984: Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat Journal of Pharmacology and Experimental Therapeutics 228(1): 133-139
Cordero de Troconis, M.I.; Pfaff, R.; Nichols, D. 1997: Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations Acta Cientifica Venezolana 48(2): 85-90
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Vorob'ev, I.N. 2005: Modeling of the mechanism of interactions of oligonucleotides with 3'-end of the yeast tRNA(Phe) Molekuliarnaia Biologiia 39(5): 887-895
Jacobs, B.L. 1991: Norepinephrine-serotonin interactions in brain Polish Journal of Pharmacology and Pharmacy 43(3): 231-239
Watanabe, Y. 1983: Interactions of cerebral serotonin and catecholamines Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 81(5): 365-383
Ranganathan, S. 2001: Molecular modeling on the Web Biotechniques 30(1): 50-52
Náray-Szabó, G. 1998: Methods of computer-assisted molecular modeling Acta Pharmaceutica Hungarica 68(1): 7-13
Scharpf, R.; Garrett, E.S.; Hu, J.; Parmigiani, G. 2003: Statistical modeling and visualization of molecular profiles in cancer Biotechniques Suppl: 22-29
Simpson, G.; Fisher, C.; Wright, D.K. 2001: Modeling the interactions between a prosthetic socket, polyurethane liners and the residual limb in transtibial amputees using non-linear finite element analysis Biomedical Sciences Instrumentation 37: 343-347
Hoegl, L.; Korting, H.C.; Klebe, G. 1999: Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age Die Pharmazie 54(5): 319-329